supported by the Beijing Natural Science Foundation(No.Z230021);the National Natural Science Foundation of China(No.52202356);the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences(No.2021-RC350-001);the CAMS Innovation Fund for Medical Sciences(No.2022-I2M-1-013).
The cyclic guanosine monophosphate-adenosine monophosphate synthase and the stimulator of interferon genes(cGAS-STING)has emerged as a promising target for cancer immunotherapy.However,the development of natural STING...
Novel peptide-fentanyl analogue conjugates were synthesized by the covalent coupling of carfentanyl derivatives to the C-terminus or N-terminus of the conformationally constrained dermorphin tetrapeptide BVD03 via a c...
supported by grants from the National Natural Science Foundation of China (No. 2140222)
GPR40 has emerged as an attractive drug target for the treatment of type 2 diabetes due to its role in the enhancement of insulin secretion with glucose dependency. With the aim to improve the metabolic and safety pro...
supported by a grant from the Postgraduate Innovation Project of Jiangsu Province,China(No. CX09B_284Z);the Natural Science Foundation of Jiangsu Province,China(No.BK2012378)
Seventeen novel ilexgenin A hybrids(lA-aspirin) and(IA-NO),as donor hybrids(IA-NO will release NO in vivo and function as NO donor),were designed and synthesized in order to develop new multi-targeting agents fo...
In the quest for novel PPARα/γ dual agonists as putative drugs for the treatment of type 2 diabetes and dyslipidemia, we designed and synthesized a series of urea acetates as potential PPARα/γ dual agonists. The s...
supported by the National High Technology Research and Development Program of China(863 project:2003AA235010);the National Natural Science Foundation of China(No.30472092).
A new series of compounds, 2-(benzodioxol-2-yl)acetic acids, have been synthesized. Their structures were confirmed by MS and 1H-NMR. The preliminary pharmacological screening showed that these compounds exhibited p...
A 3 D-QSAR about nAChRs agonists-epibatidine analogues was performed using the CoMFA and CoMSIA. The correlation coefficients were R2cv = 0.546, R2ncv = 0.907 in CoMFA and R2cv = 0.655, R2ncv = 0.962 in CoMSIA of the...